The City gave short shrift to Bio-Progress, down 18p, or 36%, to 31¼p after it warned that profits at its BioTec Films subsidiary in Tampa, Florida, were not as strong as previously expected. The group, which makes delivery mechanisms for the pharmaceuticals industry, is conducting a full financial review.